AKT1 and hereditary pheochromocytoma-paraganglioma: PI3K‐Akt signaling pathway is a key driver in carcinogenesis and Akt overactivation has been verified in various endocrine gland neoplasms, including thyroid carcinoma subtypes, parathyroid carcinoma, pituitary tumor, and pheochromocytoma.34